| Name | methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate |
|---|---|
| Synonyms |
Benzoic acid,8-dioxooctyl]oxy]-,methyl ester (MP-shape)
Methylparaben suberohydroxamic acid phenyl ester Remetinostat |
| Description | Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC[1]. |
| References |
| Molecular Formula | C16H21NO6 |
|---|---|
| Molecular Weight | 323.34100 |
| Exact Mass | 323.13700 |
| PSA | 101.93000 |
| LogP | 2.61550 |
| Storage condition | 2-8℃ |